Theoretical models that can be applied to address therapeutic adherence.

Keywords: Theoretical models, therapeutic adherence, change in behavior

Abstract

Therapeutic adherence is defined by the WHO as "the degree to which patients' behavior, in relation to taking medication, following a diet or making lifestyle changes, corresponds to the recommendations agreed with the healthcare professional." Good adherence implies control of the disease, greater effectiveness of the treatment and an improvement in the patient's quality of life, while lack of adherence can lead to serious complications of the disease, ineffectiveness of the treatment and an increase in healthcare costs. Non-adherence to pharmacological treatment is a prevalent and relevant problem in clinical practice and needs to be addressed by interventions that are supported by using theoretical models of behavior change that focus on understanding and improving people's ability to follow medical indications. The aim of this review is to mention some theoretical models of behavioral change that can be used by health professionals as scientific support for the design of interventions to address nonadherence considering cognitive, motivational and environmental aspects.

 

Downloads

Download data is not yet available.

References

Sabaté, E, Adherence to long term therapies: evidence for action. World Health Organization; 2009.

Pagès Puigdemont N, Valverde Merino M. Adherencia terapéutica: factores modificadores y estrategias de mejora. Ars Pharm. 2018; 251-258.

Torres Robles A, I Benrimoj S, Gastelurrutia M, Martínez Martínez F, Peiró T, Pérez Escamilla B, García Cárdenas V. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ. 2021; 1-11.

Oatoobservatorio.com. [citado el 19 de febrero de 2024]. Disponible en: http://www.oatobservatorio.com/wp-content/uploads/2015/10/Resumen-resultados-EstudioAdherencia-Madrid.pdf.

Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. American Psychologista. 1992; 1102-1114.

Prochaska JO, Redding C, Evers K. The Transtheoretical Model. En: Glanz K LF, Rimer BK, eds. Health behavior and health education: theory, research, and practice. San Francisco, Jossey-Bass; 1997.

Horne R. Patients beliefs about treatment the hidden determinant of treatment outcome? Journal of Psychosomatic Research. 1999; 91-495.

García-Allen J. El Modelo Transteórico del Cambio de Prochaska y Diclemente [Internet]. organización pym. 2015 [citado el 2 de marzo de 2024]. Disponible en: https://psicologiaymente.com/psicologia/modelo-transteorico-cambio-prochaska-diclemente.

Moreno E, Rosales J. El modelo de creencias de salud: revisión teórica, consideración crítica y propuesta alternativa: hacia un análisis funcional de las creencias en salud. International Journal of Psychology and Pychological Therapy. 2003; (1):91-109.

Matarazzo, J D. Behavioural health and behavioural medicina. Frontiers of a new health psychology. American Psychologist. 1980; 35, 807-817.

Fisher W, Fisher J, Shuper P. Social psychology and the fight against AIDS: An Information-Motivation-Behavioral Skills Model for the Prediction and Promotion of Health Behavior Change. Advances in Experimental Social Psychology. 2014; 105-193.

Rivera Mercado S, Villouta Cassinelli F, Ilabaca Grez A. Entrevista motivacional: ¿Cuál es su efectividad en problemas prevalentes de la atención primaria? Evidencia en medicina de familia. 2008; 257-261.

Paho.org. [citado el 19 de febrero de 2024]. Disponible en: https://www.paho.org/hq/dmdocuments/2012/WHO-Adherence-Long-Term-Therapies-Spa-2003.pdf

Ramos Morales L. La adherencia al tratamiento en las enfermedades crónicas. Rev Cubana Angiol Cir Vasc. 2015; 175-189.

Vrijens B, De Geest S, Hughes D, Przemyslaw K, Demonceau J, Ruppar T, Urquhart J. A new taxonomy for describing and defining adherence to medications. British journal of clinical pharmacology. 2012; 691-705.

Sefac.org. [citado el 19 de febrero de 2024]. Disponible en: https://www.sefac.org/sites/default/files/sefac2010/private/documentos_sefac/documentos/farmaindustria-plan-de-adherencia.pdf

Valverde Merino M, Martinez Martinez F, García Mochon L, Benrimoj S, Malet Larrea A, Pérez Escamilla B, Zarzuelo M, Torres Robles A, Gastelurrutia M, Varas Doval R, Peiro Zorrilla T, García Cardenas V. Cost Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community Pharmacy. Patient Preference and Adherence. 2021; 2363–2376.

SEFH - Sociedad Española de Farmacia Hospitalaria [Internet]. SEFH. [citado el 19 de febrero de 2024]. Disponible en: https://www.sefh.es

Benavides A, Jaramillo Rosero L, Rendón S, Valenzuela A, Argotty Pérez E, Mafla A. Determinantes de adherencia al tratamiento antihipertensivo de adultos ≥ 35 años de edad. Univ. Salud. 2013; (15), 136-149.

Martínez Martínez F. Informe Global 2019 AdherenciaMED: Diseño, evaluación del impacto e implantación de un Servicio profesional de Adherencia Terapéutica desde el ámbito de la Farmacia Comunitaria. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos. 2019.

Adams AJ, Stolpe SF. Defining and measuring primary medication nonadherence: development of a quality measure. J Manag Care Spec Pharm, 2016; (22):516-23. 12.

REFERENCES

Sabaté, E, Adherence to long term therapies: evidence for action. World Health Organization; 2009.

Pagès Puigdemont N, Valverde Merino M. Adherencia terapéutica: factores modificadores y estrategias de mejora. Ars Pharm. 2018; 251-258.

Torres Robles A, I Benrimoj S, Gastelurrutia M, Martínez Martínez F, Peiró T, Pérez Escamilla B, García Cárdenas V. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ. 2021; 1-11.

Oatoobservatorio.com. [citado el 19 de febrero de 2024]. Disponible en: http://www.oatobservatorio.com/wp-content/uploads/2015/10/Resumen-resultados-EstudioAdherencia-Madrid.pdf

Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. American Psychologista. 1992; 1102-1114.

Prochaska JO, Redding C, Evers K. The Transtheoretical Model. En: Glanz K LF, Rimer BK, eds. Health behavior and health education: theory, research, and practice. San Francisco, Jossey-Bass; 1997.

Horne R. Patients beliefs about treatment the hidden determinant of treatment outcome? Journal of Psychosomatic Research. 1999; 91-495.

García-Allen J. El Modelo Transteórico del Cambio de Prochaska y Diclemente [Internet]. organización pym. 2015 [citado el 2 de marzo de 2024]. Disponible en: https://psicologiaymente.com/psicologia/modelo-transteorico-cambio-prochaska-diclemente

Moreno E, Rosales J. El modelo de creencias de salud: revisión teórica, consideración crítica y propuesta alternativa: hacia un análisis funcional de las creencias en salud. International Journal of Psychology and Pychological Therapy. 2003; (1):91-109.

Matarazzo, J D. Behavioural health and behavioural medicina. Frontiers of a new health psychology. American Psychologist. 1980; 35, 807-817.

Fisher W, Fisher J, Shuper P. Social psychology and the fight against AIDS: An Information-Motivation-Behavioral Skills Model for the Prediction and Promotion of Health Behavior Change. Advances in Experimental Social Psychology. 2014; 105-193.

Rivera Mercado S, Villouta Cassinelli F, Ilabaca Grez A. Entrevista motivacional: ¿cuál es su efectividad en problemas prevalentes de la atención primaria? Evidencia en medicina de familia. 2008; 257-261

Paho.org. [citado el 19 de febrero de 2024]. Disponible en: https://www.paho.org/hq/dmdocuments/2012/WHO-Adherence-Long-Term-Therapies-Spa-2003.pdf

Ramos Morales L. La adherencia al tratamiento en las enfermedades crónicas. Rev Cubana Angiol Cir Vasc. 2015; 175-189.

Vrijens B, De Geest S, Hughes D, Przemyslaw K, Demonceau J, Ruppar T, Urquhart J. A new taxonomy for describing and defining adherence to medications. British journal of clinical pharmacology. 2012; 691-705.

Sefac.org. [citado el 19 de febrero de 2024]. Disponible en: https://www.sefac.org/sites/default/files/sefac2010/private/documentos_sefac/documentos/farmaindustria-plan-de-adherencia.pdf

Valverde Merino M, Martinez Martinez F, García Mochon L, Benrimoj S, Malet Larrea A, Pérez Escamilla B, Zarzuelo M, Torres Robles A, Gastelurrutia M, Varas Doval R, Peiro Zorrilla T, García Cardenas V. Cost Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community Pharmacy. Patient Preference and Adherence. 2021; 2363–2376.

SEFH - Sociedad Española de Farmacia Hospitalaria [Internet]. SEFH. [citado el 19 de febrero de 2024]. Disponible en: https://www.sefh.es

Benavides A, Jaramillo Rosero L, Rendón S, Valenzuela A, Argotty Pérez E, Mafla A. Determinantes de adherencia al tratamiento antihipertensivo de adultos ≥ 35 años de edad. Univ. Salud. 2013; (15), 136-149.

Martínez Martínez F. Informe Global 2019 AdherenciaMED: Diseño, evaluación del impacto e implantación de un Servicio profesional de Adherencia Terapéutica desde el ámbito de la Farmacia Comunitaria. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos. 2019.

Adams AJ, Stolpe SF. Defining and measuring primary medication nonadherence: development of a quality measure. J Manag Care Spec Pharm, 2016; (22):516-23. 12.

Consejo General de Colegios Oficiales de Farmaceut. Informe de resultados AdherenciaMED. Informe global. Granada: Consejo General de Colegios Oficiales de Farmacéuticos. 2019.

Secretaría de Salud. Guía clínica para el médico de primer nivel de atención de adherencia terapéutica. 2017.

Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication nonadherence: analysis of electronic prescriptions. J Gen Intern Med. 2010; (25):284-90.

Moreno E, Rosales J. El modelo de creencias de salud: revisión teórica, consideración crítica y propuesta alternativa: hacia un análisis funcional de las creencias en salud. International Journal of Psychology and Pychological Therapy. 2003; (1):91-109).

Johnston M. Psicología de la salud: perspectivas europeas. Papeles del Psicólogo. 1990; (1), 46-47.

Reyes Rodríguez L. La Teoría de la Acción Razonada: Implicaciones para el estudio de las actitudes. INED. 2007; 66-67.

Stefani, D. Teoría de la acción razonada: una aplicación a la problemática de la internación geriátrica. Revista Latinoamericana de Psicología. 1993; 25 (2), 205-223.

Reasoned Action Model. Modelos Psicológicos de la Salud que han abordado el VIH/SIDA. 2024.

Wordpress.com. [citado el 19 de febrero de 2024]. Disponible en: https://promsalud.files.wordpress.com/2012/02/modelos-pedagogicos-en-salud.pdf

Jiménez MP. Motivación y salud, emoción y motivación, la adaptación humana. 2003; 831-854. Madrid: Centro de estudios Ramón Areces SA.

Rogers R. Cognitive and Psychological processes in fear appeals and attitude change. A revised theory of protection motivation. Psychophysiology: A Sourcebook 1983; 153-177.

Leventhal H, Meyer D. y Nerenz DR. The common-sense representation of illness danger. Contributions to Medical Psychology. New York: Pergamon Press.1980; 7-30.

Leventhal H, Diefenbach M. The active side of illness cognition. Mental representation in health and illness New York: Springer-Verlag. 1991; 247-272.

Meyer D, Leventhal H, Gutmann M. Common sense models of illness: the example of hypertension. Health Psychology. 1985; 115-135.

Fisher JD, Fisher WA, Bryan AD, Misovich SJ. Information-motivation-behavioral skills model-based HIV risk behavior change intervention for inner-city high school youth. Health Psychology. 2002; 177–186.

Bandura A. Organizational Application of Social Cognitive Theory. Australian Journal of Management. 1988; 275 - 302.

Olivari Medina C, Urra Medina E. Autoeficacia y conductas de salud. Ciencia y enfermería XVIII. 2007; 9-15.

Bandura A, Vittorio Caprara G, Barbaranelli C, Gerbino M, Pastorelli C. Role of Affective Self-Regulatory Efficacy in Diverse Spheres of Psychosocial Functioning. Child Development. 2003; 769 - 782.

Riquelme M. Metodología de educación para la salud. Rev Pediatr Aten Primaria. 2012; 77-82.

Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Progress In Behavior Modification. 1992; 183-218

Bleda JM. Promoción y educación para la salud. España: Asociación Castellana Manchega de sociología. 2020; 219-220.

Macmillaneducation.es. [citado el 19 de febrero de 2024]. Disponible en: https://www.macmillaneducation.es/wpcontent/uploads/2019/02/pap_unidad_cast.pdf

Martínez Domínguez G, Martínez Sánchez L, Lopera Valle J, Vargas Grisales N. La importancia de la adherencia terapéutica. Rev Venez Endocrinol Metab. 2016; p 107-116.

Miller WR. Motivational interviewing: research, practice, and puzzles. Addict Behav. 1996; 835-842.

Horne R, Weinman J, Barber N, et al. Concordance, Adherence and Compliance in Medicine Taking. 2005.

Lehane E, McCarthy G. Intentional and unintentional medication non adherence: A comprehensive framework for clinical research and practice? A discussion paper. International journal of nursing studies. 2007;44(8):1468-1477.

Bae SG, Kam S, Park KS, et al. Factors related to intentional and unintentional medication no adherence in elderly patients with hypertension in rural community. Patient preference and adherence. 2016; (10):1979-1989.

Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patient’s adherence related beliefs about medicines prescribed for long term conditions: a meta-analytic review of the Necessity-Concerns Framework. 2023.

Phillips LA, Diefenbach MA, Kronish IM, Negron RM, Horowitz CR. The necessity concerns framework: a multidimensional theory benefits from multidimensional analysis. Annals of behavioral medicine: a publication of the Society of Behavioral Medicine. 2014; 7-16.

Foot H, La Caze A, Gujral G, Cottrell N. The necessity concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis. Patient education and counseling. 2016; 706-717.

Bowers KA. Explaining health behavior: the health belief model. Nursing administration quarterly. 1980;4(2):41-46.

Carpenter CJ. A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health communication. 2010;25(8):661-669.

Kamran A, Sadeghieh Ahari S, Biria M, Malepour A, Heydari H. Determinants of Patient’s Adherence to Hypertension Medications: Application of Health Belief Model Among Rural Patients. Annals of medical and health sciences research. 2014;4(6):922-927.

DiMatteo MR, Haskard Zolnierek KB, Martin LR. Improving patient adherence: a three-factor model to guide practice. Health Psychology Review. 2012; 74-91.

Martin LR, Feig C, Maksoudian CR, Wysong K, Faasse K. A perspective on nonadherence to drug therapy: psychological barriers and strategies to overcome nonadherence. Patient preference and adherence. 2018; 1527-1535.

Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. American journal of health promotion: AJHP;12(1). 1997:38-48)

Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational Interviewing Improves Medication Adherence: a Systematic Review and Meta-analysis. Journal of general internal medicine. 2016;31(8):929-940.

Spears J, Erkens J, Misquitta C, Cutler T, Stebbins M. A Pharmacist-Led, Patient-Centered Program Incorporating Motivational Interviewing for Behavior Change to Improve Adherence Rates and Star Ratings in a Medicare Plan. Journal of managed care & specialty pharmacy. 2020; 26(1):35-41.

Maffoni M, Traversoni S, Costa E. Medication adherence in the older adults with chronic multimorbidity: a systematic review of qualitative studies on patient’s experience. European geriatric medicine. 2020. 369-381.

Published
2024-08-13
How to Cite
Jiménez Melo, A. (2024). Theoretical models that can be applied to address therapeutic adherence. Mexican Journal of Medical Research ICSA, 13(25). Retrieved from https://repository.uaeh.edu.mx/revistas/index.php/MJMR/article/view/12404